Argaw-Denboba A, Balestrieri E, Serafino A, Cipriani C, Bucci I, Sorrentino R, Sciamanna I, Gambacurta A, Sinibaldi-Vallebona P, Matteucci C (2017) HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features. J Exp Clin Cancer Res 36:20

Article  PubMed  PubMed Central  Google Scholar 

Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J (2005) Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res 65:4172–4180

Article  PubMed  Google Scholar 

Cioffi M, D’Alterio C, Camerlingo R, Tirino V, Consales C, Riccio A, Ierano C, Cecere SC, Losito NS, Greggi S et al (2015) Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer. Sci Rep 5:10357

Article  ADS  PubMed  PubMed Central  Google Scholar 

Curty G, Marston JL, de Mulder RM, Leal FE, Nixon DF, Soares MA (2020) Human endogenous retrovirus K in cancer: a potential biomarker and immunotherapeutic target. Viruses 12:726

Article  CAS  PubMed  PubMed Central  Google Scholar 

Downey RF, Sullivan FJ, Wang-Johanning F, Ambs S, Giles FJ, Glynn SA (2015) Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice? Int J Cancer 137:1249–1257

Article  CAS  PubMed  Google Scholar 

Fuchs NV, Loewer S, Daley GQ, Izsvak Z, Lower J, Lower R (2013) Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells. Retrovirology 10:115

Article  PubMed  PubMed Central  Google Scholar 

Garcia-Montojo M, Doucet-O’Hare T, Henderson L, Nath A (2018) Human endogenous retrovirus-K (HML-2): a comprehensive review. Crit Rev Microbiol 44:715–738

Article  PubMed  PubMed Central  Google Scholar 

Glumac PM, LeBeau AM (2018) The role of CD133 in cancer: a concise review. Clin Transl Med 7:18

Article  PubMed  PubMed Central  Google Scholar 

Jiang W, Peng J, Zhang Y, Cho WC, Jin K (2012) The implications of cancer stem cells for cancer therapy. Int J Mol Sci 13:16636–16657

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ko EJ, Cha HJ (2021) The roles of human endogenous retroviruses (HERVs) in inflammation. Kosin Med J 36:69–78

Article  Google Scholar 

Ko EJ, Ock MS, Choi YH, Iovanna JL, Mun S, Han K, Kim HS, Cha HJ (2021) Human endogenous retrovirus (HERV)-K env gene knockout affects tumorigenic characteristics of nupr1 gene in DLD-1 colorectal cancer cells. Int J Mol Sci 22(8):3941

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ko EJ, Kim ET, Kim H, Lee CM, Koh SB, Eo WK, Kim H, Oh YL, Ock MS, Kim KH et al (2022) Effect of human endogenous retrovirus-K env gene knockout on proliferation of ovarian cancer cells. Genes Genom 44:1091–1097

Article  CAS  Google Scholar 

Liu CL, Chen YJ, Fan MH, Liao YJ, Mao TL (2020) Characteristics of CD133-sustained chemoresistant cancer stem-like cells in human ovarian carcinoma. Int J Mol Sci 21:6467

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matteucci C, Balestrieri E, Argaw-Denboba A, Sinibaldi-Vallebona P (2018) Human endogenous retroviruses role in cancer cell stemness. Semin Cancer Biol 53:17–30

Article  CAS  PubMed  Google Scholar 

Narayan S, Bryant G, Shah S, Berrozpe G, Ptashne M (2017) OCT4 and SOX2 work as transcriptional activators in reprogramming human fibroblasts. Cell Rep 20:1585–1596

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379–391

Article  CAS  PubMed  Google Scholar 

Schaefer T, Lengerke C (2020) SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond. Oncogene 39:278–292

Article  CAS  PubMed  Google Scholar 

Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauss A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U (2020) Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol 11:1280

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang T, Medynets M, Johnson KR, Doucet-O’Hare TT, DiSanza B, Li W, Xu Y, Bagnell A, Tyagi R, Sampson K et al (2020) Regulation of stem cell function and neuronal differentiation by HERV-K via mTOR pathway. Proc Natl Acad Sci U S A 117:17842–17853

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, Rosen DG, Chen DT, Lu DW, Barnhart KF, Johanning GL (2007) Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer 120:81–90

Article  CAS  PubMed  Google Scholar 

Yamashita T, Wang XW (2013) Cancer stem cells in the development of liver cancer. J Clin Invest 123:1911–1918

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu P, Nie Q, Tang C, Zhang L (2018) Nanog induced intermediate state in regulating stem cell differentiation and reprogramming. BMC Syst Biol 12:22

Article  PubMed  PubMed Central  Google Scholar